Improving the safety of blood transfusion by using a combination of two screening assays for hepatitis C virus-Reference-Cited by-同舟云学术

Improving the safety of blood transfusion by using a combination of two screening assays for hepatitis C virus

Published:2014-09-29 Issue:5 Volume:24 Page:297-304
ISSN:0958-7578
Container-title:Transfusion Medicine
language:en
Short-container-title:Transfusion Med

Author:

Zhang K.¹,Wang L.¹,Sun Y.¹,Zhang R.¹,Lin G.¹,Xie J.¹,Li J.¹

Affiliation:

1. National Center for Clinical Laboratories; Beijing Hospital; Beijing People's Republic of China

Funder

Chinese Ministry of Health Special Fund for Public Welfare

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tme.12152/fullpdf

Reference34 articles.

1. Safety and efficacy of hepatitis C virus antibody screening of blood donors with two sequential screening assays;Allain;Transfusion,1996

2. Hepatitis C virus (HCV)-specific T-cell responses among recombinant immunoblot assay-3-indeterminate blood donors: a confirmatory evidence of HCV exposure;Bes;Transfusion,2009

3. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors;Busch;Transfusion,2005

4. Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors;Busch;Transfusion,2006

5. Public Health Service inter-agency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C;Centers for Disease Control and Prevention;MMWR - Recommendations and Reports,1991

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diverse Genotypes of Hepatitis C Virus in Voluntary Blood Donors in Shanghai, China;Hepatitis Monthly;2017-06-17

2. Application of a Grey Zone for HCV and HIV Immunoassays for Blood Donor Screening: Is It still Necessary?;The Korean Journal of Blood Transfusion;2015-08-30

3. Is Anti-Hepatitis C Virus Antibody Level an Appropriate Marker to Preclude the Need for Supplemental Testing?;Intervirology;2015